Publication | Open Access

Identification of SART3-derived peptides having the potential to induce cancer-reactive cytotoxic T lymphocytes from prostate cancer patients with HLA-A3 supertype alleles

Sart3-derived PeptidesCancer ImmunosurveillanceT-regulatory CellProstate Cancer PatientsImmunologyImmunoeditingPathologyAntigen ProcessingAutoimmunityHla TypingImmunotherapyMedicineHla-a3 Supertype Alleles